Novavax posts first profitable quarter as Covid vaccine rolls out around the world

Novavax reported net income of $203 million in the first quarter, compared to a net loss of $222.7 million the same period last year.

from Health and Science https://ift.tt/KxnXu0C
https://ift.tt/Kl6WLZb
https://ift.tt/nSswb1N